FONDAZIONE PER L'ISTITUTO ONCOLOGICO DI...
Desconocido
CLLCLONE: Harnessing clonal evolution in chronic lymphocytic leukemia
FONDAZIONE PER LISTITUTO ONCOLOGICO DI RICERCA IOR
tramitó un
H2020:
ERC-2017-COG
Chronic lymphocytic leukemia (CLL), the most common leukemia in adults, is addicted of interactions with the microenvironment. The B-cell re...
2018-02-07 - 2023-06-30 | Financiado
2018-02-07 - 2023-06-30 | Financiado
Immune-senescence: Dual targeting of senescence and tumor immunity for cancer therapy
FONDAZIONE PER LISTITUTO ONCOLOGICO DI RICERCA IOR
tramitó un
H2020:
ERC-2015-CoG
We have previously demonstrated that cellular senescence opposes tumorigenesis thereby opening up new potential opportunities for cancer tre...
2016-06-23 - 2021-06-30 | Financiado
2016-06-23 - 2021-06-30 | Financiado
* No se disponen de datos de la empresa actual.